FDA sets PDUFA target action date of June 5, 2022NEWTON, Mass. and GENEVA, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acer...
First Phase 3 Study is Initiated to Evaluate Safety and Efficacy of Simufilam Over 52 Weeks in 750 Patients with...
Increases in lumbar spine, femoral neck and total hip BMD demonstrated with EB613 Linear Dose Responses Seen in Biomarker and...
Patents strengthen Acasti’s IP portfolio and provide protection through 2036 and 2037, respectivelyLAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) --...
FLORHAM PARK, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Quanta, Inc. Figure 1.1 BURBANK, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a...
Acquisition Delivers AI and Data Engineering Expertise, Enterprise Analytics and Technology-Enabled Solutions to Accelerate Customer PerformanceMORRISVILLE, N.C., Oct. 06, 2021...
Teladoc Health Primary360 Teladoc Health Reimagines Primary Care with Primary360 New Primary Care Model Delivers Greater Care Access & Health...
- BD0801, discovered using Apexigen’s APXiMAB™ antibody technology platform, is in development by Simcere in China through a licensing agreement -SAN...
ORANGE, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, a leading mission-based Medicare Advantage insurance company, will introduce the...
SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing...
The first patient was dosed at MD Anderson as part of a multicenter clinical trial to evaluate the safety and...
Triggers upfront payment of approximately $150 million to Caelum shareholders, of which approximately $64 million is payable to Fortress Biotech1...
AMITYVILLE, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Greenrose Acquisition Corp. (OTC: GNRSU, GNRS, GNRSW) (“Greenrose” or the “Company”), a...
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated...
SAN CARLOS, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA), a company focused on developing cellular and cell...
PRESS RELEASE 6 October 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that...
Dr. Erik van der Heijden Radboudumc Nijmegen Lung biopsy using Philips 3D navigation - 1 Lung biopsy using Philips 3D...
DALLAS, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented...
SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery...
